[Results of a clinico-laboratory study and of a clinical trial of compound SK-1 in the combined treatment of inflammatory periodontal disease].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003487:Cyanoacrylates / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D003738:Dental Cements / Q000627:therapeutic use*; D006801:Humans; D010510:Periodontal Diseases / Q000188:drug therapy; D010511:Periodontal Dressings / Q000627:therapeutic use; D010518:Periodontitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D003487:Cyanoacrylates; D003692:Delayed-Action Preparations; D003738:Dental Cements
Rezul'taty kliniko-laboratornogo izucheniia i klinicheskoĭ aprobatsii kompozitsii SK-1 pri kompleksnom lechenii vospalitel'nykh zabolevaniĭ parodonta.